Figure 2.
Figure 2. IFN-γ staining of peripheral blood lymphocytes of responding and nonresponding patients with mAA. Lymphocytes from 11 previously untreated patients with mAA were surface stained with CD4-tricolor (phycoerythrin-cyanine 5) and CD8-PE and intracellularly stained with IFN-γ-FITC. Patients with mAA received daclizumab therapy and were designated as responders or nonresponders based on improvement of bone marrow function by 3 months following treatment. The figure shows the ratio of MCFsample/MCFisotype of staining of peripheral blood lymphocytes. Values more than 2 SD above the mean of normal were said to be positive for IFN-γ.17 MCF indicates mean channel fluorescence.

IFN-γ staining of peripheral blood lymphocytes of responding and nonresponding patients with mAA. Lymphocytes from 11 previously untreated patients with mAA were surface stained with CD4-tricolor (phycoerythrin-cyanine 5) and CD8-PE and intracellularly stained with IFN-γ-FITC. Patients with mAA received daclizumab therapy and were designated as responders or nonresponders based on improvement of bone marrow function by 3 months following treatment. The figure shows the ratio of MCFsample/MCFisotype of staining of peripheral blood lymphocytes. Values more than 2 SD above the mean of normal were said to be positive for IFN-γ.17  MCF indicates mean channel fluorescence.

Close Modal

or Create an Account

Close Modal
Close Modal